As expected from the role of Runx2 in angiogenesis, RUNX2 is expressed at higher levels in cancers such as osteosarcoma, colon, prostate, and thyroid cancers as well as melanoma [13,94,95,96], suggesting its oncogenic role. This evidence concerns the gene RUNX2 and melanoma.